By API User
The Leukaemia Foundation and Haematology Society of Australia and New Zealand (HSANZ) have again partnered to award three of Australia’s brightest blood cancer researchers and clinicians with PhD scholarships. The 2024 recipients were announced last night at the annual Blood conference in Brisbane and include Dr Elizabeth Goodall, Dr Stephen Ma, and Dr Sean … Continued
By API User
This October, the MePACS Monitored Personal Alarm Service celebrates 35 years of helping people to feel safe and maintain their independence. MePACS, originally called the Mt Eliza Personal Alarm Care Service, provides a monitored personal alarm service to Australians – including seniors, people living with disability or chronic conditions and lone workers. MePACS offers immediate help … Continued
By API User
Key presentations at Eyecelerator in Chicago and AusBiotechInvest Conference PolyActiva is developing biodegradable ocular implants that provide sustained drug delivery, with its lead product targeting glaucoma, the second most common cause of irreversible blindness. Lead candidate, PA5108, met safety and efficacy endpoints in its Phase 2 clinical trial and demonstrated repeat dosing capability. Patients received … Continued
By API User
Improving contraceptive knowledge among young women from rural and remote areas of Australia is the focus of a study by the SPHERE Centre of Research Excellence at Monash University. Women living in rural and remote areas of Australia are 1.4 times more likely to experience an unintended pregnancy than those living in urban areas, and … Continued
By API User
Catholic Health Australia (CHA) is urging the federal government to review its decision to remove fibrin sealants from the Prescribed List on November 1 until alternative funding arrangements are in place, warning it could severely disrupt essential surgical procedures and increase costs for patients and hospitals. Fibrin sealants are crucial in managing bleeding risks during … Continued
By API User
From this Friday, November 1, landmark laws come into effect across Australia, removing barriers, which for too long, prevented nurse practitioners (NPs) and endorsed midwives from prescribing medicines under the PBS and providing services under Medicare because of the outdated requirement for a ‘collaborative arrangement’ with a medical practitioner. The Federal Secretary of the Australian … Continued
By API User
FREIBURG, GERMANY / ACCESSWIRE / October 29, 2024 / Today, Dr. Falk Pharma GmbH announces the successful acquisition of Kynos Therapeutics Ltd., a clinical stage biopharmaceutical company focusing on the development of novel treatments for patients suffering from acute and chronic inflammatory diseases. The company was founded as a spin-out of the University of Edinburgh, … Continued
By API User
GHENT, Belgium, Oct. 29, 2024 (GLOBE NEWSWIRE) — Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with GMP facilities in Belgium, Spain, the Netherlands and Sweden, today announced a substantial expansion of its Bioanalytical Services in the Netherlands. This strategic investment includes establishing a brand new bioanalytical lab at Ardena’s Pivot Park facility … Continued
By API User
29 October 2024 Australia’s peak body for Public Health has responded to the COVID-19 Response Inquiry report, saying that the emphasis on an Australian Centre for Disease Control is the correct approach to help the country prepare for future infectious disease outbreaks, as well as the persistent challenges of non-communicable diseases. “As the COVID-19 outbreak … Continued
By API User
LTR Pharma Limited (ASX:LTP) (“LTR Pharma”, “the Company”), a Company focused on improving men’s health through clinical development and commercialisation of an innovative nasal spray treatment for erectile dysfunction (“ED”), SPONTAN®, is pleased to provide its Appendix 4C for the quarter ended 30 September 2024. Highlights: SPONTAN® prescribed to first patients under the Therapeutic Goods … Continued
